哥倫比亞銀行系統 COLB 深 滬
等待開盤 12-23 09:30:00 美东时间
29.02
+0.170
+0.59%
華盛通- 最 高29.26
- 今 開29.02
- 成交量 254.87万股
- 最 低 28.89
- 昨 收 28.85
- 總市值 86.77亿
- 52周最高 29.61
- 市盈率 靜 11.38
- 換手率 0.85%
- 52周最低 18.52
- 委 比 -60.14%
- 總股本 2.99亿
- 歷史最高 44.35
- 量 比 0.91
- 振 幅 1.28%
- 歷史最低 -2.08
- 每 手 1
- 風險率 2.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
12-22 15:05
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
12-18 10:54
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
12-17 10:46
JP Morgan Maintains Neutral on Columbia Banking System, Raises Price Target to $33
JP Morgan analyst Anthony Elian maintains Columbia Banking System (NASDAQ:COLB) with a Neutral and raises the price target from $31 to $33.
12-16 23:39
Columbia Banking System Raises Dividend From $0.36 To $0.37/Share
Columbia Banking System, Inc. ("Columbia" Nasdaq: COLB), parent company of Columbia Bank, today announced its Board of Directors has approved a quarterly cash dividend in the amount of $0.37 per common share,
11-14 21:17
Columbia Banking System Announces Increase to Common Share Dividend
TACOMA, Wash., Nov. 14, 2025 /PRNewswire/ -- Columbia Banking System, Inc. ("Columbia" Nasdaq: COLB), parent company of Columbia Bank, today announced its Board of Directors has approved a q...
11-14 21:15
HOLDCO ASSET MANAGEMENT RELEASES PRESENTATION TO COLUMBIA BANKING SYSTEM, INC.
FORT LAUDERDALE, Fla., Nov. 6, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets un...
11-06 21:55
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
Citigroup Maintains Neutral on Columbia Banking System, Raises Price Target to $28
Citigroup analyst Ben Gerlinger maintains Columbia Banking System (NASDAQ:COLB) with a Neutral and raises the price target from $26 to $28.
11-01 04:10
Columbia Banking System Announces CFO Transition
Ronald Farnsworth, Executive Vice President, CFO, to Step Down Ivan Seda, Deputy CFO, Appointed CFO, Effective December 31, 2025 TACOMA, Wash., Oct. 30, 2025 /PRNewswire/ -- Columbia Banking...
10-31 04:12
